At Gnosis by Lesaffre, we want to support you by taking care of your cardiovascular health.
In 2019, the World Health Organization estimated that cardiovascular events cause one-third of global deaths. Of these deaths, 85% were due to heart attack and stroke.
In seek for strategies to promote heart health and prevent the related risk factors for cardiovascular disease (CVD)are more researched and studied. Among them, homocysteine‐lowering interventions due to folate supplementation.
In the 5th issue, the brochure is dedicated to the link between folate and cardiovascular health.
Quatrefolic® and Cardiovascular health
This issue of the Quatrefolic® 360° series focuses on the likely correlation between folate supplementation and cardiovascular health.
Download your copy to discover:
- The homocysteine (Hcy) mechanisms
- The interconnection between folate, Hcy and CVD
- Quatrefolic® benefits for cardiovascular health
Quatrefolic®, already in the form of active folate and not dependent by MTHFR enzyme, may appear as the right nutritional folate support, suitable for 100% of its consumers.
DISCOVER ALL OUR LATEST NEWS
Exciting Insights into Longevity:
Vital Nutrients Symposium 2025 Is Just Around the Corner
The countdown has begun for the Vital Nutrients Symposium 2025, which will take place from April 2nd to 3rd in Kassel, Germany. This exclusive event will bring together experts from science and industry to explore the forward-looking topic of Longevity—not just living longer but living better.
Safety of S-Acetyl Glutathione confirmed for food and dietary supplements
Celebrating a new milestone: Safety assessment of S-Acetyl Glutathione for food and dietary supplement use has been published in the Food and Chemical Toxicology journal.
The Role of Bioavailability in Improving Health Benefits
In the fast-growing dietary supplement industry, innovation goes beyond new products to focus on enhancing the effectiveness of their ingredients.
The improved bioavailability of Quatrefolic® has been proven through various studies, such as a pharmacokinetic study and an assessment of the final product.
